Clinicopathological value of somatostatin type 2A and estrogen receptor immunoreactivity in human breast carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-03

AUTHORS

Monika Pilichowska, Noriko Kimura, Akihiko Suzuki, Ryuichi Yoshida, Marcus Schindler, Hiroshi Nagura

ABSTRACT

Somatostatin type 2A (sstr2A) and estrogen receptor (ER) are interrelated regulatory receptors present in normal breast epithelium and in a population of breast carcinomas. ER mediates growth stimulatory effects of estrogens whereas sstr2A mediates growth inhibitory actions of somatostatin. However, much work has been devoted to elucidate the biological role of ER, little is known about sstr2A in breast cancer. In the present study we examined immunoreactivity of sstr2A and ER in 64 breast carcinomas in correlation with tumor size and histological grade (HG), presence of lymph node metastasis (LNM), Nottingham prognostic index (NPI), and the patients' age. ER and sstr2A immunoreactivity were present in 78% and 63% of the breast carcinomas, respectively. Ninety percent of tumors immunoreactive for sstr2A were simultaneously immunoreactive for ER. ER immunoreactivity correlated significantly with lower HG (p=0.03) and better NPI (p=0.02). sstr2 A immunoreactivity correlated significantly with lower HG (p=0.012) but not with NPI (p=0.26). There was no correlation of sstr2A immunoreactivity and tumor size, patients' chronological age or LNM. The results confirm prognostic value of ER immunohistochemistry in breast carcinoma. However sstr2A cannot substitute ER for prognostic evaluation, sstr2A immunoreactivity being significantly associated with lower HG seems to represent an independent prognostic factor in breast carcinoma. More... »

PAGES

55-61

Identifiers

URI

http://scigraph.springernature.com/pub.10.1385/ep:12:1:55

DOI

http://dx.doi.org/10.1385/ep:12:1:55

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044828639

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11478269


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Ductal, Breast", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Lobular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Medullary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoenzyme Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymph Nodes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphatic Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Estrogen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Somatostatin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Tufts University School of Medicine, 750 Washington Street, 02111, Boston, MA", 
          "id": "http://www.grid.ac/institutes/grid.429997.8", 
          "name": [
            "Department of Pathology, Tufts University School of Medicine, 750 Washington Street, 02111, Boston, MA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pilichowska", 
        "givenName": "Monika", 
        "id": "sg:person.01175665722.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175665722.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Tohoku Rosai Hospital, Boston, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pathology, Tohoku Rosai Hospital, Boston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kimura", 
        "givenName": "Noriko", 
        "id": "sg:person.01223337420.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223337420.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Tohoku University School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Department of Surgery, Tohoku University School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Akihiko", 
        "id": "sg:person.01173753623.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173753623.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Tohoku University School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Department of Surgery, Tohoku University School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshida", 
        "givenName": "Ryuichi", 
        "id": "sg:person.01242067023.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242067023.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Glaxo Institute of Applied Pharmacology, Cambridge, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Glaxo Institute of Applied Pharmacology, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schindler", 
        "givenName": "Marcus", 
        "id": "sg:person.010765267642.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010765267642.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Tohoku University School of Medicine, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Department of Pathology, Tohoku University School of Medicine, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagura", 
        "givenName": "Hiroshi", 
        "id": "sg:person.0723362470.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723362470.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1987.230", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047698959", 
          "https://doi.org/10.1038/bjc.1987.230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01807890", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022209532", 
          "https://doi.org/10.1007/bf01807890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1978.282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020541320", 
          "https://doi.org/10.1038/bjc.1978.282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01806300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044335652", 
          "https://doi.org/10.1007/bf01806300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1989.154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049383045", 
          "https://doi.org/10.1038/bjc.1989.154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1957.43", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033483945", 
          "https://doi.org/10.1038/bjc.1957.43"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/291076a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032827964", 
          "https://doi.org/10.1038/291076a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690226", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030877048", 
          "https://doi.org/10.1038/sj.bjc.6690226"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1385/ep:11:1:57", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001947066", 
          "https://doi.org/10.1385/ep:11:1:57"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1997.143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042325904", 
          "https://doi.org/10.1038/bjc.1997.143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006132427948", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053618775", 
          "https://doi.org/10.1023/a:1006132427948"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-03", 
    "datePublishedReg": "2001-03-01", 
    "description": "Somatostatin type 2A (sstr2A) and estrogen receptor (ER) are interrelated regulatory receptors present in normal breast epithelium and in a population of breast carcinomas. ER mediates growth stimulatory effects of estrogens whereas sstr2A mediates growth inhibitory actions of somatostatin. However, much work has been devoted to elucidate the biological role of ER, little is known about sstr2A in breast cancer. In the present study we examined immunoreactivity of sstr2A and ER in 64 breast carcinomas in correlation with tumor size and histological grade (HG), presence of lymph node metastasis (LNM), Nottingham prognostic index (NPI), and the patients' age. ER and sstr2A immunoreactivity were present in 78% and 63% of the breast carcinomas, respectively. Ninety percent of tumors immunoreactive for sstr2A were simultaneously immunoreactive for ER. ER immunoreactivity correlated significantly with lower HG (p=0.03) and better NPI (p=0.02). sstr2 A immunoreactivity correlated significantly with lower HG (p=0.012) but not with NPI (p=0.26). There was no correlation of sstr2A immunoreactivity and tumor size, patients' chronological age or LNM. The results confirm prognostic value of ER immunohistochemistry in breast carcinoma. However sstr2A cannot substitute ER for prognostic evaluation, sstr2A immunoreactivity being significantly associated with lower HG seems to represent an independent prognostic factor in breast carcinoma.", 
    "genre": "article", 
    "id": "sg:pub.10.1385/ep:12:1:55", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100468", 
        "issn": [
          "1046-3976", 
          "1559-0097"
        ], 
        "name": "Endocrine Pathology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "Nottingham Prognostic Index", 
      "low histological grade", 
      "lymph node metastasis", 
      "histological grade", 
      "breast carcinoma", 
      "estrogen receptor", 
      "sstr2A immunoreactivity", 
      "tumor size", 
      "good Nottingham's prognostic Index", 
      "estrogen receptor immunoreactivity", 
      "patient's chronological age", 
      "independent prognostic factor", 
      "percent of tumors", 
      "type 2A", 
      "normal breast epithelium", 
      "human breast carcinoma", 
      "growth stimulatory effect", 
      "growth inhibitory action", 
      "chronological age", 
      "ER immunohistochemistry", 
      "patient age", 
      "receptor immunoreactivity", 
      "node metastasis", 
      "ER immunoreactivity", 
      "prognostic factors", 
      "prognostic index", 
      "prognostic value", 
      "clinicopathological value", 
      "prognostic evaluation", 
      "breast cancer", 
      "breast epithelium", 
      "regulatory receptors", 
      "carcinoma", 
      "immunoreactivity", 
      "inhibitory action", 
      "SSTR2A", 
      "stimulatory effect", 
      "age", 
      "receptors", 
      "present study", 
      "biological role", 
      "somatostatin", 
      "metastasis", 
      "estrogen", 
      "SSTR2", 
      "immunohistochemistry", 
      "tumors", 
      "cancer", 
      "epithelium", 
      "correlation", 
      "percent", 
      "grade", 
      "population", 
      "index", 
      "factors", 
      "evaluation", 
      "study", 
      "role", 
      "action", 
      "effect", 
      "presence", 
      "values", 
      "size", 
      "results", 
      "work"
    ], 
    "name": "Clinicopathological value of somatostatin type 2A and estrogen receptor immunoreactivity in human breast carcinoma", 
    "pagination": "55-61", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044828639"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1385/ep:12:1:55"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11478269"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1385/ep:12:1:55", 
      "https://app.dimensions.ai/details/publication/pub.1044828639"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_314.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1385/ep:12:1:55"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1385/ep:12:1:55'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1385/ep:12:1:55'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1385/ep:12:1:55'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1385/ep:12:1:55'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      115 URIs      96 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1385/ep:12:1:55 schema:about N108a11865a5c4428a176c945ed445f7d
2 N1e1899859ff4495b84a7763a1638b649
3 N5624bc7864f94513b526d642f5bb2fa7
4 N6173db3c72794e918a463550c2c7513a
5 N82c719c7673f4f379448e9522e4923b2
6 N8529536538c5445faab3127ac31956b0
7 N89946c4139274c6a8d81d98eaab38d86
8 N959cce6eeda4486fbe66e5ce073e9c8c
9 Nb39cf69c9fab4982b15974d8ddb1f724
10 Ncffe61b55dda41248dd7d352890e5b04
11 Nd46a4d8f2e294560b00f752efb7c4a1e
12 Nd4d65c0b990e4ad0b71cf70a44034b63
13 Ndc5db4107e3b423695d0cb92d6e5adc8
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N29161357cd144c7385fdfc900a074263
17 schema:citation sg:pub.10.1007/bf01806300
18 sg:pub.10.1007/bf01807890
19 sg:pub.10.1023/a:1006132427948
20 sg:pub.10.1038/291076a0
21 sg:pub.10.1038/bjc.1957.43
22 sg:pub.10.1038/bjc.1978.282
23 sg:pub.10.1038/bjc.1987.230
24 sg:pub.10.1038/bjc.1989.154
25 sg:pub.10.1038/bjc.1997.143
26 sg:pub.10.1038/sj.bjc.6690226
27 sg:pub.10.1385/ep:11:1:57
28 schema:datePublished 2001-03
29 schema:datePublishedReg 2001-03-01
30 schema:description Somatostatin type 2A (sstr2A) and estrogen receptor (ER) are interrelated regulatory receptors present in normal breast epithelium and in a population of breast carcinomas. ER mediates growth stimulatory effects of estrogens whereas sstr2A mediates growth inhibitory actions of somatostatin. However, much work has been devoted to elucidate the biological role of ER, little is known about sstr2A in breast cancer. In the present study we examined immunoreactivity of sstr2A and ER in 64 breast carcinomas in correlation with tumor size and histological grade (HG), presence of lymph node metastasis (LNM), Nottingham prognostic index (NPI), and the patients' age. ER and sstr2A immunoreactivity were present in 78% and 63% of the breast carcinomas, respectively. Ninety percent of tumors immunoreactive for sstr2A were simultaneously immunoreactive for ER. ER immunoreactivity correlated significantly with lower HG (p=0.03) and better NPI (p=0.02). sstr2 A immunoreactivity correlated significantly with lower HG (p=0.012) but not with NPI (p=0.26). There was no correlation of sstr2A immunoreactivity and tumor size, patients' chronological age or LNM. The results confirm prognostic value of ER immunohistochemistry in breast carcinoma. However sstr2A cannot substitute ER for prognostic evaluation, sstr2A immunoreactivity being significantly associated with lower HG seems to represent an independent prognostic factor in breast carcinoma.
31 schema:genre article
32 schema:isAccessibleForFree false
33 schema:isPartOf N39cd4037914243d48d24fd01af20b1bb
34 N72b4f4330ab64ec0bd8fd2f38b0ac953
35 sg:journal.1100468
36 schema:keywords ER immunohistochemistry
37 ER immunoreactivity
38 Nottingham Prognostic Index
39 SSTR2
40 SSTR2A
41 action
42 age
43 biological role
44 breast cancer
45 breast carcinoma
46 breast epithelium
47 cancer
48 carcinoma
49 chronological age
50 clinicopathological value
51 correlation
52 effect
53 epithelium
54 estrogen
55 estrogen receptor
56 estrogen receptor immunoreactivity
57 evaluation
58 factors
59 good Nottingham's prognostic Index
60 grade
61 growth inhibitory action
62 growth stimulatory effect
63 histological grade
64 human breast carcinoma
65 immunohistochemistry
66 immunoreactivity
67 independent prognostic factor
68 index
69 inhibitory action
70 low histological grade
71 lymph node metastasis
72 metastasis
73 node metastasis
74 normal breast epithelium
75 patient age
76 patient's chronological age
77 percent
78 percent of tumors
79 population
80 presence
81 present study
82 prognostic evaluation
83 prognostic factors
84 prognostic index
85 prognostic value
86 receptor immunoreactivity
87 receptors
88 regulatory receptors
89 results
90 role
91 size
92 somatostatin
93 sstr2A immunoreactivity
94 stimulatory effect
95 study
96 tumor size
97 tumors
98 type 2A
99 values
100 work
101 schema:name Clinicopathological value of somatostatin type 2A and estrogen receptor immunoreactivity in human breast carcinoma
102 schema:pagination 55-61
103 schema:productId N0222da0ff8804abcb0adcb6a9cfd0f43
104 N6dbc9794e5b141a9bb78990f0ced45a8
105 N7a698923dbe24194aaa7420c562eca40
106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044828639
107 https://doi.org/10.1385/ep:12:1:55
108 schema:sdDatePublished 2022-08-04T16:52
109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
110 schema:sdPublisher N06b8f97133a24b7d888cc1fc6fdfa00b
111 schema:url https://doi.org/10.1385/ep:12:1:55
112 sgo:license sg:explorer/license/
113 sgo:sdDataset articles
114 rdf:type schema:ScholarlyArticle
115 N0222da0ff8804abcb0adcb6a9cfd0f43 schema:name dimensions_id
116 schema:value pub.1044828639
117 rdf:type schema:PropertyValue
118 N06b8f97133a24b7d888cc1fc6fdfa00b schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 N108a11865a5c4428a176c945ed445f7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Carcinoma, Medullary
122 rdf:type schema:DefinedTerm
123 N1d74e392192b4aab91f9e683c9632c16 rdf:first sg:person.0723362470.15
124 rdf:rest rdf:nil
125 N1e1899859ff4495b84a7763a1638b649 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Receptors, Somatostatin
127 rdf:type schema:DefinedTerm
128 N29161357cd144c7385fdfc900a074263 rdf:first sg:person.01175665722.04
129 rdf:rest Nb12b06dc5f1a48f082b9884c0cc93547
130 N39cd4037914243d48d24fd01af20b1bb schema:issueNumber 1
131 rdf:type schema:PublicationIssue
132 N482a59e186474bf28b1b03051a2d112b rdf:first sg:person.01242067023.59
133 rdf:rest Ne8cb9f1d39464f25bb38321a8a1ed4cd
134 N5624bc7864f94513b526d642f5bb2fa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 N6173db3c72794e918a463550c2c7513a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Breast Neoplasms
139 rdf:type schema:DefinedTerm
140 N6dbc9794e5b141a9bb78990f0ced45a8 schema:name doi
141 schema:value 10.1385/ep:12:1:55
142 rdf:type schema:PropertyValue
143 N72b4f4330ab64ec0bd8fd2f38b0ac953 schema:volumeNumber 12
144 rdf:type schema:PublicationVolume
145 N7a698923dbe24194aaa7420c562eca40 schema:name pubmed_id
146 schema:value 11478269
147 rdf:type schema:PropertyValue
148 N82c719c7673f4f379448e9522e4923b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Prognosis
150 rdf:type schema:DefinedTerm
151 N8529536538c5445faab3127ac31956b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Lymphatic Metastasis
153 rdf:type schema:DefinedTerm
154 N89946c4139274c6a8d81d98eaab38d86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Lymph Nodes
156 rdf:type schema:DefinedTerm
157 N959cce6eeda4486fbe66e5ce073e9c8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Carcinoma, Lobular
159 rdf:type schema:DefinedTerm
160 Naf2bd222a009412c91b53a763ae83e4c rdf:first sg:person.01173753623.32
161 rdf:rest N482a59e186474bf28b1b03051a2d112b
162 Nb12b06dc5f1a48f082b9884c0cc93547 rdf:first sg:person.01223337420.14
163 rdf:rest Naf2bd222a009412c91b53a763ae83e4c
164 Nb39cf69c9fab4982b15974d8ddb1f724 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Immunoenzyme Techniques
166 rdf:type schema:DefinedTerm
167 Ncffe61b55dda41248dd7d352890e5b04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Middle Aged
169 rdf:type schema:DefinedTerm
170 Nd46a4d8f2e294560b00f752efb7c4a1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Carcinoma, Ductal, Breast
172 rdf:type schema:DefinedTerm
173 Nd4d65c0b990e4ad0b71cf70a44034b63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Female
175 rdf:type schema:DefinedTerm
176 Ndc5db4107e3b423695d0cb92d6e5adc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Receptors, Estrogen
178 rdf:type schema:DefinedTerm
179 Ne8cb9f1d39464f25bb38321a8a1ed4cd rdf:first sg:person.010765267642.98
180 rdf:rest N1d74e392192b4aab91f9e683c9632c16
181 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical and Health Sciences
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
185 schema:name Oncology and Carcinogenesis
186 rdf:type schema:DefinedTerm
187 sg:journal.1100468 schema:issn 1046-3976
188 1559-0097
189 schema:name Endocrine Pathology
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.010765267642.98 schema:affiliation grid-institutes:None
193 schema:familyName Schindler
194 schema:givenName Marcus
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010765267642.98
196 rdf:type schema:Person
197 sg:person.01173753623.32 schema:affiliation grid-institutes:grid.69566.3a
198 schema:familyName Suzuki
199 schema:givenName Akihiko
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173753623.32
201 rdf:type schema:Person
202 sg:person.01175665722.04 schema:affiliation grid-institutes:grid.429997.8
203 schema:familyName Pilichowska
204 schema:givenName Monika
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175665722.04
206 rdf:type schema:Person
207 sg:person.01223337420.14 schema:affiliation grid-institutes:None
208 schema:familyName Kimura
209 schema:givenName Noriko
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223337420.14
211 rdf:type schema:Person
212 sg:person.01242067023.59 schema:affiliation grid-institutes:grid.69566.3a
213 schema:familyName Yoshida
214 schema:givenName Ryuichi
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242067023.59
216 rdf:type schema:Person
217 sg:person.0723362470.15 schema:affiliation grid-institutes:grid.69566.3a
218 schema:familyName Nagura
219 schema:givenName Hiroshi
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723362470.15
221 rdf:type schema:Person
222 sg:pub.10.1007/bf01806300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044335652
223 https://doi.org/10.1007/bf01806300
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/bf01807890 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022209532
226 https://doi.org/10.1007/bf01807890
227 rdf:type schema:CreativeWork
228 sg:pub.10.1023/a:1006132427948 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053618775
229 https://doi.org/10.1023/a:1006132427948
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/291076a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032827964
232 https://doi.org/10.1038/291076a0
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/bjc.1957.43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033483945
235 https://doi.org/10.1038/bjc.1957.43
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/bjc.1978.282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020541320
238 https://doi.org/10.1038/bjc.1978.282
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/bjc.1987.230 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047698959
241 https://doi.org/10.1038/bjc.1987.230
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/bjc.1989.154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049383045
244 https://doi.org/10.1038/bjc.1989.154
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/bjc.1997.143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042325904
247 https://doi.org/10.1038/bjc.1997.143
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/sj.bjc.6690226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030877048
250 https://doi.org/10.1038/sj.bjc.6690226
251 rdf:type schema:CreativeWork
252 sg:pub.10.1385/ep:11:1:57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001947066
253 https://doi.org/10.1385/ep:11:1:57
254 rdf:type schema:CreativeWork
255 grid-institutes:None schema:alternateName Department of Pathology, Tohoku Rosai Hospital, Boston, USA
256 Glaxo Institute of Applied Pharmacology, Cambridge, UK
257 schema:name Department of Pathology, Tohoku Rosai Hospital, Boston, USA
258 Glaxo Institute of Applied Pharmacology, Cambridge, UK
259 rdf:type schema:Organization
260 grid-institutes:grid.429997.8 schema:alternateName Department of Pathology, Tufts University School of Medicine, 750 Washington Street, 02111, Boston, MA
261 schema:name Department of Pathology, Tufts University School of Medicine, 750 Washington Street, 02111, Boston, MA
262 rdf:type schema:Organization
263 grid-institutes:grid.69566.3a schema:alternateName Department of Pathology, Tohoku University School of Medicine, Sendai, Japan
264 Department of Surgery, Tohoku University School of Medicine, Sendai, Japan
265 schema:name Department of Pathology, Tohoku University School of Medicine, Sendai, Japan
266 Department of Surgery, Tohoku University School of Medicine, Sendai, Japan
267 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...